PE anti-human CD196 (CCR6) 353409 from BioLegend

Product Specs
ItemPE anti-human CD196 (CCR6)
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number353409
NCBI Gene AliasesBN-1, C-C CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22
Quantity25 tests
ApplicationsFlow Cytometry (FC)
CloneG034E3
HostMouse
ReactivityHuman, Cynomolgus, Rhesus
IsotypeIgG2b, Kappa
Conjugate/TagPE
Antibody TypePrimary
NCBI Full Gene NameC-C motif chemokine receptor 6
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ImmunogenCCR6-transfected cells
ClonalityMonoclonal
TargetCD196

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formationImmunityFebruary 14, 2023Thomas Krausgruber, Anna Redl, Daniele Barreca, Konstantin Doberer, Daria Romanovskaia, Lina Dobnikar, Maria Guarini, Luisa Unterluggauer, Lisa Kleissl, Denise Atzmüller, et al.RESOURCE,SOURCE,IDENTIFIER Antibodies,Antibodies,Antibodies ,, CCL19,R&D systems,Clone: 54909; Cat# MAB361; RRID: AB_2071417 CCR6 – PE,Biolegend,Clone: G034E3; Cat# 353409; RRID: AB_10915968 CCR7 – PE,Biolegend,Clone: G043H7; Cat# 353204; RRID: AB_10913813 CD3 – PE/Dazzle

(2) CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotypeOncogeneJanuary 1, 2023Zeng W, Xiong L, Wu W, Li S, Liu J, Yang L, Lao L, Huang P, Zhang M, Chen H, et al.(BioLegend, #342406), CD44 (BD Biosciences, #555478), CD24 (BD Biosciences, #55542), CCR6 (BioLegend, #353409) and CCR8 (BioLegend, #360603) for 30 min at 4 °C. To evaluate cell surface PITPNM3 expression, cells

(3) Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cellsPLOS ONEOctober 21, 2021Paul A. Wilson et al.day 6 of culture and stained for Live/Dead Aqua (Invitrogen #L34957), CCR6 PE (BioLegend #353410 and #353409), CXCR3 APC (BD #561732), and CD4 BV421 (BioLegend #317434) for 45 minutes on ice. After staining, cells

(4) Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal centerNPJ vaccinesJanuary 25, 2021Eslamizar L, Petrovas C, Leggat DJ, Furr K, Lifton ML, Levine G, Ma S, Fletez-Brant C, Hoyland W, Prabhakaran M, et al.

(5) Novel biallelic TRNT1 mutations lead to atypical SIFD and multiple immune defectsGenes & diseasesMarch 1, 2020Yang L, Xue X, Zeng T, Chen X, Zhao Q, Tang X, Yang J, An Y, Zhao X.

(6) Anti-inflammatory effects of Lactobacillus johnsonii L531 in a pig model of Salmonella Infantis infection involves modulation of CCR6⁺ T cell responses and ER stressVeterinary researchFebruary 24, 2020Yang GY, Xia B, Su JH, He T, Liu X, Guo L, Zhang S, Zhu YH, Wang JF.

(7) Clonal replacement of tumor-specific T cells following PD-1 blockadeNature medicineAugust 1, 2019Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, et al.cat. no. 317417, lot no. B207751, BioLegend), anti-human-CCR6 conjugated to PE (clone G034E3, cat. no. 353409, lot no. B203239, BioLegend), anti-human-CD25 conjugated to FITC (clone BC96, cat. no. 302603, lot no.

(8) Transcript-indexed ATAC-seq for precision immune profilingNature medicineMay 1, 2018Satpathy AT, Saligrama N, Buenrostro JD, Wei Y, Wu B, Rubin AJ, Granja JM, Lareau CA, Li R, Qi Y, et al.(Clone OKT4, Lot# B207751, Cat# 317417, Biolegend), anti-human CCR6-PE (Clone G034E3, Lot# B203239, Cat# 353409, Biolegend), anti-human CD25-FITC (Clone BC96, Lot# B168869, Cat# 302603, Biolegend), anti-human CXCR3-Brilliant

(9) Phenotypic Characterization of Circulating CD4⁺ T Cells in ANCA-Associated VasculitisJournal of immunology researchJanuary 1, 2018Lilliebladh S, Johansson Å, Pettersson Å, Ohlsson S, Hellmark T.

(10) Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC InhibitorsCancer cellJuly 10, 2017Qu K, Zaba LC, Satpathy AT, Giresi PG, Li R, Jin Y, Armstrong R, Jin C, Schmitt N, Rahbar Z, et al.

(11) Distinct Transcriptional and Alternative Splicing Signatures of Decidual CD4⁺ T Cells in Early Human PregnancyFrontiers in immunologyJanuary 1, 2017Zeng W, Liu Z, Liu X, Zhang S, Khanniche A, Zheng Y, Ma X, Yu T, Tian F, Liu XR, et al.

(12) Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjectsJournal of leukocyte biologyOctober 1, 2016Pandya JM, Lundell AC, Hallström M, Andersson K, Nordström I, Rudin A.

(13) Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B CellsJournal of immunology (Baltimore, Md. : 1950)May 15, 2016Li H, Borrego F, Nagata S, Tolnay M.

(14) Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosusScientific reportsSeptember 23, 2015Yin S, Mao Y, Li X, Yue C, Zhou C, Huang L, Mo W, Liang D, Zhang J, He W, et al.

(15) Cholera toxin directly enhances IL-17A production from human CD4+ T cellsJournal of immunology (Baltimore, Md. : 1950)October 15, 2013Tsai HC, Wu R.

(16) [Phylogenetic aspects of acquired immunity]OnkologieJune 1, 1978V Lapin

Be the First to Write a Review!

PLOS ONE

PE anti-human CD196 (CCR6) from BioLegend

Description

BioLegend

Citations (16)

Reviews

PE anti-human CD196 (CCR6) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map